Author

Juan C. Lopez

Observed names: J. Lopez, J.C. Cruz López, Juan Carlos Cruz Lopez, Juan Carlos Cruz López

Institution: Memorial Sloan Kettering Cancer Center

Observed institutions: Memorial Sloan Kettering Cancer Center, Hospital General Universitario Gregorio Marañón, Frederick National Laboratory for Cancer Research, Science Applications International Corporation (United States), Institute for Social Security and Services for State Workers

OpenAlex ID: A5113740771

Relative Replication Fitness of a High-Level 3′-Azido-3′-Deoxythymidine-Resistant Variant of Human Immunodeficiency Virus Type 1 Possessing an Amino Acid Deletion at Codon 67 and a Novel Substitution (Thr→Gly) at Codon 69

2000 · Tomozumi Imamichi, Steve C. Berg, et al. · Journal of Virology · 78

Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses

2017 · Lifen Ling, Samuel E. Kaplan, et al. · Journal of Clinical Microbiology · 63

Alternating chemotherapy: Gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer

2012 · J.L. Aguilar-Ponce, M. Granados-García, et al. · Oral Oncology · 13

The Clinical Performance of the BioCode Respiratory Pathogen Panel for the Detection of Viruses and Bacteria from Nasopharyngeal Swabs

2023 · Xin Zhang, Colleen Knoth, et al. · Microbiology Spectrum · 2

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC).

2021 · Imane H. El Dika, Susan Michelle Geyer, et al. · Journal of Clinical Oncology · 2

Pharmacogenetic biomarkers associated with paclitaxel response in Mexican women with locally advanced breast cancer.

2016 · Andric Christopher Perez-Ortiz, Cynthia Villarreal-Garza, et al. · Journal of Clinical Oncology · 2

Cáncer de mama con receptores hormonales positivos: tratamiento adyuvante, primera línea en cáncer metastásico y nuevas estrategias (inhibición de mTOR)

2015 · Iván Romarico González Espinoza, Cynthia Villarreal Garza, et al. · Gaceta Mexicana de Oncología · 1

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy Signature

2023 · Aldo Moreno-Ulloa, Vareska L. Zárate-Córdova, et al. · Research Square

Tall Cell Histology – Comparison of T1 Tall Cell Variant and Classical Papillary Thyroid Carcinoma

2022 · R.S.R. Woods, C.W.R. Fitzgerald, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 9

Citation count: 161

H-index: 3

I10-index: 3